WebDiakron Pharmaceuticals, Inc. is a cardiovascular drug development company focused on clinically differentiated products for significant cardiovascular markets. Diakron will … WebNov 2, 2010 - Diakron Pharmaceuticals, Inc. Improved process for the preparation of 3-fluoro-2-pyridylmethyl-3-(2,2-difluoro-2-(2-pyridyl)ethylamino)-6-chloropyrazin-2-one-1-acetamide of formula (I) and its intermediates is provided. Latest …
Diakron Pharmaceuticals Licenses Anticoagulant Drug Candidate …
WebTo participate in Diakron which holds the worldwide rights for the compound. Orchid Chemicals & Pharmaceuticals Ltd., (“Orchid”), the Chennai (India) based pharmaceuticals major has announced that it would be undertaking the development and manufacture of an anti-coagulant drug candidate initially discovered and developed through Phase I by … WebDiakron Pharmaceuticals, Inc. announced today the signing of an exclusive license agreement for a novel investigational oral anticoagulant drug candidate discovered and … biltmore dining chairs
Diakron Pharmaceuticals Company Profile: Acquisition & Investors PitchBook
WebFor the biopharma industry investment, business development and competitive intelligence professionals who require information to support financing, partnering and licensing … WebAug 13, 2008 · Diakron Pharmaceuticals, Inc. is a privately-owned pharmaceutical company specializing in the development of products for the treatment of certain cardiovascular … WebDiakron Pharmaceuticals Inc PO Box 748 Morris Plains, New Jersey 07950-0748 Phone: 201.404.5705 Website Website Links Latest news Description Diakron Pharmaceuticals, Inc. is a cardiovascular drug development company focused on clinically differentiated products for significant cardiovascular markets. cynthia pottle newfoundland